These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9688305)

  • 21. Induction of immune resistance against L1210 lymphatic leukemia in mice after lethal irradiation and reconstruction with fetal liver cells.
    Skórski T; Ratajczak MZ; Kawalec M; Kawiak J
    Folia Histochem Cytobiol; 1991; 29(3):121-4. PubMed ID: 1794437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of dihydroxyanthraquinone and radiation on L1210 murine leukemia.
    Kimler BF; Hacker MP
    Cancer Clin Trials; 1981; 4(2):173-6. PubMed ID: 7249253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adoptive immunotherapy and chemo-immunotherapy in murine L-1210 leukemia and its influence on the kinetics of leukemic proliferation.
    Rytwiński K
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):819-27. PubMed ID: 549532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of concanavalin A-bound L1210 vaccine in vivo by chemotherapeutic agents.
    Kataoka T; Kobayashi H; Sakurai Y
    Cancer Res; 1978 May; 38(5):1202-7. PubMed ID: 639053
    [No Abstract]   [Full Text] [Related]  

  • 25. Augmented antitumour effects of combination therapy with TNP-470 and chemoimmunotherapy in mice.
    Dabrowska-Iwanicka A; Olszewska D; Jalili A; Makowski M; Grzela T; Marczak M; Hoser G; Giermasz A; Golab J; Jakóbisiak M
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):433-42. PubMed ID: 12200600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effects of Actinobacillus suis cells in combination with 5-fluorouracil on mice bearing murine L1210 leukemia cells.
    Watanabe T; Itoh S
    Cancer Immunol Immunother; 1997 Jun; 44(4):216-20. PubMed ID: 9222280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukiemia.
    Canti G; Calastretti A; Bevilacqua A; Reddi E; Palumbo G; Nicolin A
    Neoplasma; 2010; 57(2):184-8. PubMed ID: 20099984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antileukemic properties of organoplatinum complexes.
    Meischen SJ; Gale GR; Lake LM; Frangakis CJ; Rosenblum MG; Walker EM; Atkins LM; Smith AB
    J Natl Cancer Inst; 1976 Oct; 57(4):841-5. PubMed ID: 1003531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of adoptive immunotherapy by cis-diamminedichloroplatinum(II), but not by doxorubicin, on a disseminated mouse lymphoma and its association with reduction of tumor burden.
    Formelli F; Rossi C; Sensi ML; Parmiani G
    Int J Cancer; 1988 Dec; 42(6):952-7. PubMed ID: 3263956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemia.
    Mathé G; Halle-Pannenko O; Bourut C
    Eur J Cancer (1965); 1974 Oct; 10(10):661-6. PubMed ID: 4465103
    [No Abstract]   [Full Text] [Related]  

  • 31. Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy.
    Yue T; Zheng X; Dou Y; Zheng X; Sun R; Tian Z; Wei H
    BMC Cancer; 2016 Aug; 16(1):665. PubMed ID: 27549240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity in glioma cells due to interleukin-12 and interleukin-18-stimulated macrophages mediated by interferon-gamma-regulated nitric oxide.
    Kito T; Kuroda E; Yokota A; Yamashita U
    J Neurosurg; 2003 Feb; 98(2):385-92. PubMed ID: 12593627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma.
    Haas GP; Klugo RC; Hetzel FW; Barton EE; Cerny JC
    J Urol; 1984 Oct; 132(4):828-33. PubMed ID: 6540817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.
    Eralp Y; Wang X; Wang JP; Maughan MF; Polo JM; Lachman LB
    Breast Cancer Res; 2004; 6(4):R275-83. PubMed ID: 15217493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of efficacy of antitumor agents by conagenin.
    Kawatsu M; Yamashita T; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1995 Mar; 48(3):222-5. PubMed ID: 7730156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Bekesi JG; Roboz JP; Zimmerman E; Holland JF
    Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced antitumor response mediated by the codelivery of paclitaxel and adenoviral vector expressing IL-12.
    Cao L; Zeng Q; Xu C; Shi S; Zhang Z; Sun X
    Mol Pharm; 2013 May; 10(5):1804-14. PubMed ID: 23534449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
    Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D
    Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH; Wallace TL; Richard KA; Tracey DE
    Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
    Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.